Navigation Links
Omeros Chosen to Present at NewsMakers in the Biotech Industry 2013 Conference
Date:9/20/2013

SEATTLE, Sept. 20, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the NewsMakers in the Biotech Industry 2013 Conference in New York City next week.  The presentation is scheduled for Friday, September 27, 2013 at 2:00 p.m. EDT.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery® platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has six clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the pharmaceutical industry. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Contact:
Jennifer Cook Williams
Cook Williams Communications, Inc.
Inve
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
2. Omeros Reports Additional Positive Results from OMS824 Program
3. Omeros Submits OMS302 Marketing Authorization Application to European Medicines Agency
4. Omeros to Present at the Stifel Healthcare Conference 2013
5. Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
6. Omeros Corporation Reports Second Quarter 2013 Financial Results
7. Omeros to Present at the Wedbush 2013 Life Sciences Management Access Conference
8. Omeros Submits New Drug Application to U.S. FDA for OMS302
9. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
10. Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program
11. Omeros Corporation Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014  The University of Maryland,s A. James Clark ... of the new A. James Clark Hall at the ... cultivate transformative new engineering and biomedical technologies to accelerate ... 10:00 a.m. on November 21 at the site of ... adjacent to the Jeong H. Kim Engineering Building, the ...
(Date:11/21/2014)... SAN CLEMENTE, Calif. , Nov. 21, 2014 /PRNewswire/ ... Lab Coats and Performance Scrubs carried out a new ... the medical industry,s very first "limited edition" lab ... the first female professors of surgery in the world. ... departure from its unisex predecessors, with a sleek envelope ...
(Date:11/21/2014)...  Heated dialogue in recent months about the rising ... to Gilead,s new hepatitis C drug Harvoni® – has ... what it means to put a price on patient ... while drug pricing is one of the most debated ... general business and ethical standpoint – it is also ...
Breaking Medicine Technology:University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5
... Calif., March 10, 2011 OXIS International, Inc., (OTC ... announced that it will hold a conference call with ... Eastern (8:00 a.m. Pacific). During the call ... will review significant business developments, discuss the Company,s growth ...
... 2011 STAAR Surgical Company (Nasdaq: STAA ... invasive ophthalmic products, today announced that it has entered ... the exclusive distribution of STAAR intraocular lenses in Australia. ... publicly traded in Australia, will market STAAR,s Visian ICL ...
Cached Medicine Technology:STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia 2STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia 3
(Date:11/23/2014)... November 23, 2014 Asher Milgrom, ... Aesthetics & Wellness was recently featured on ... is president and CEO of American Medical Aesthetics & ... Milgrom received a full scholarship to attend an M.D./Ph.D ... School at the University of Chicago, where his field ...
(Date:11/23/2014)... BambooFlooringChina.com , the world’s leader in bamboo flooring, ... flooring collection. Now, the business is announcing big discounts ... promotion is valid until Dec. 20, 2014. , The new ... dust-free surface, which makes it very easy to maintain. As ... wants to make its website the best shopping platform for ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress ... big promotion. Customers can buy new dresses at its ... visit its website. , As a matter of fact, ... It mainly provides four types of wedding outfits, including ... girl dresses. It also provides a variety of occasion ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Today, Dylan ... its new collection of wedding dresses; the business offers ... other related accessories for ladies worldwide, allowing them to ... manager of the company, this new collection of chic ... launch. Moreover, they are offered at discounted rates now. ...
(Date:11/22/2014)... 22, 2014 Nocturia is defined ... complaint that the individual has to wake at ... report “Nocturia – Pipeline Review, H2 2014” provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ...
Breaking Medicine News(10 mins):Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4
... PA, 23 February 2011 - Understanding the genetics of ... specific genetic variations associated with this disorder has been ... Psychiatry implicates a brain protein called Piccolo in ... of neuronal proteins, Piccolo is a member of a ...
... increasingly popular in maternity care, but healthcare professionals need ... to a review in the March issue of the ... There is also need for greater respect and cooperation ... patients about the growing use of CAM. ...
... 2011 New research shows that medications which have ... may not have gotten approval from the Food and ... retention had been better understood. Fluid retention may explain ... medications such as Vioxx, Bextra, and Avandia. The research ...
... Feb. 23 (HealthDay News) -- People,s emotional response to challenges ... a new study. To reach that conclusion, researchers from ... a laboratory in front of a video camera and a ... the speech, and they were later asked about the emotions ...
... electronic health record system in Canada, e-health policy must ... health care reform and must take a bottom-up approach ... study published in CMAJ ( Canadian Medical ... Canada Health Infoway has invested almost $1.6 billion ...
... available in French . An electronic health ... Canada and more must be done to speed up the implementation ... be put in place effectively, doctors and front line health care ... role. These are the findings of an innovative new study assessing ...
Cached Medicine News:Health News:A new clue to the genetics of bipolar disorder: Piccolo 2Health News:Review highlights need for more education and guidance on CAM use in midwifery 2Health News:Review highlights need for more education and guidance on CAM use in midwifery 3Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 2Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 3Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 4Health News:E-health must align with health care reform 2Health News:E-health must be a priority, researchers say 2
... the First and Only ... powerful technology of RESTORE with the ... create the unrivaled RESTOREPRIME. The ultimate ... coverage for managing patients with bilateral ...
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....
... PRIMEADVANCED is a nonrechargeable neurostimulator designed for ... needs or do not want the maintenance ... of their pain. What makes RESTOREADVANCED ... neurostimulators is the ease and efficiency with ...
All-natural porcine collagen can be used in open or laparoscopic placement....
Medicine Products: